Your browser doesn't support javascript.
loading
CRISPR/Cas9 delivery by NIR-responsive biomimetic nanoparticles for targeted HBV therapy.
Wang, Dan; Chen, Ling; Li, Chengbi; Long, Quanxin; Yang, Qing; Huang, Ailong; Tang, Hua.
Afiliación
  • Wang D; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, 1 Yi Xue Yuan Road, Chongqing, 400016, China.
  • Chen L; The People's Hospital of Rongchang District, Chongqing, 402460, China.
  • Li C; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, 1 Yi Xue Yuan Road, Chongqing, 400016, China.
  • Long Q; The People's Hospital of Rongchang District, Chongqing, 402460, China.
  • Yang Q; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, 1 Yi Xue Yuan Road, Chongqing, 400016, China.
  • Huang A; The People's Hospital of Rongchang District, Chongqing, 402460, China.
  • Tang H; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, 1 Yi Xue Yuan Road, Chongqing, 400016, China.
J Nanobiotechnology ; 20(1): 27, 2022 Jan 06.
Article en En | MEDLINE | ID: mdl-34991617

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Materiales Biomiméticos / Nanopartículas / Sistemas CRISPR-Cas / Edición Génica / Hepatitis B Límite: Animals Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Materiales Biomiméticos / Nanopartículas / Sistemas CRISPR-Cas / Edición Génica / Hepatitis B Límite: Animals Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article País de afiliación: China